Table of Contents Executive Summary 1 Industry Overview of Pulmonary Hypertension Drug 1.1 Definition of Pulmonary Hypertension Drug 1.2 Pulmonary Hypertension Drug Segment by Type 1.2.1 Global Pulmonary Hypertension Drug Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Prostacyclin and Prostacyclin Analogs 1.2.3 Endothelin Receptor Antagonists 1.2.4 Phosphodiesterase-5 Inhibitors 1.2.5 Soluble Guanylate Cyclase Stimulators 1.3 Pulmonary Hypertension Drug Segment by Applications 1.3.1 Global Pulmonary Hypertension Drug Consumption Comparison by Applications (2014-2025) 1.3.2 Early-stage Drug Candidates (Phase I & Phase II) 1.3.3 Late-stage Drug Candidates (Phase III & Registration Phase) 1.4 Global Pulmonary Hypertension Drug Overall Market 1.4.1 Global Pulmonary Hypertension Drug Revenue (2014-2025) 1.4.2 Global Pulmonary Hypertension Drug Production (2014-2025) 1.4.3 North America Pulmonary Hypertension Drug Status and Prospect (2014-2025) 1.4.4 Europe Pulmonary Hypertension Drug Status and Prospect (2014-2025) 1.4.5 China Pulmonary Hypertension Drug Status and Prospect (2014-2025) 1.4.6 Japan Pulmonary Hypertension Drug Status and Prospect (2014-2025) 1.4.7 Southeast Asia Pulmonary Hypertension Drug Status and Prospect (2014-2025) 1.4.8 India Pulmonary Hypertension Drug Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Pulmonary Hypertension Drug 2.3 Manufacturing Process Analysis of Pulmonary Hypertension Drug 2.4 Industry Chain Structure of Pulmonary Hypertension Drug 3 Development and Manufacturing Plants Analysis of Pulmonary Hypertension Drug 3.1 Capacity and Commercial Production Date 3.2 Global Pulmonary Hypertension Drug Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Pulmonary Hypertension Drug 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Pulmonary Hypertension Drug Production and Capacity Analysis 4.2 Pulmonary Hypertension Drug Revenue Analysis 4.3 Pulmonary Hypertension Drug Price Analysis 4.4 Market Concentration Degree 5 Pulmonary Hypertension Drug Regional Market Analysis 5.1 Pulmonary Hypertension Drug Production by Regions 5.1.1 Global Pulmonary Hypertension Drug Production by Regions 5.1.2 Global Pulmonary Hypertension Drug Revenue by Regions 5.2 Pulmonary Hypertension Drug Consumption by Regions 5.3 North America Pulmonary Hypertension Drug Market Analysis 5.3.1 North America Pulmonary Hypertension Drug Production 5.3.2 North America Pulmonary Hypertension Drug Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Pulmonary Hypertension Drug Import and Export 5.4 Europe Pulmonary Hypertension Drug Market Analysis 5.4.1 Europe Pulmonary Hypertension Drug Production 5.4.2 Europe Pulmonary Hypertension Drug Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Pulmonary Hypertension Drug Import and Export 5.5 China Pulmonary Hypertension Drug Market Analysis 5.5.1 China Pulmonary Hypertension Drug Production 5.5.2 China Pulmonary Hypertension Drug Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Pulmonary Hypertension Drug Import and Export 5.6 Japan Pulmonary Hypertension Drug Market Analysis 5.6.1 Japan Pulmonary Hypertension Drug Production 5.6.2 Japan Pulmonary Hypertension Drug Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Pulmonary Hypertension Drug Import and Export 5.7 Southeast Asia Pulmonary Hypertension Drug Market Analysis 5.7.1 Southeast Asia Pulmonary Hypertension Drug Production 5.7.2 Southeast Asia Pulmonary Hypertension Drug Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Pulmonary Hypertension Drug Import and Export 5.8 India Pulmonary Hypertension Drug Market Analysis 5.8.1 India Pulmonary Hypertension Drug Production 5.8.2 India Pulmonary Hypertension Drug Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Pulmonary Hypertension Drug Import and Export 6 Pulmonary Hypertension Drug Segment Market Analysis (by Type) 6.1 Global Pulmonary Hypertension Drug Production by Type 6.2 Global Pulmonary Hypertension Drug Revenue by Type 6.3 Pulmonary Hypertension Drug Price by Type 7 Pulmonary Hypertension Drug Segment Market Analysis (by Application) 7.1 Global Pulmonary Hypertension Drug Consumption by Application 7.2 Global Pulmonary Hypertension Drug Consumption Market Share by Application (2014-2019) 8 Pulmonary Hypertension Drug Major Manufacturers Analysis 8.1 GlaxoSmithKline plc 8.1.1 GlaxoSmithKline plc Pulmonary Hypertension Drug Production Sites and Area Served 8.1.2 GlaxoSmithKline plc Product Introduction, Application and Specification 8.1.3 GlaxoSmithKline plc Pulmonary Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Novartis AG 8.2.1 Novartis AG Pulmonary Hypertension Drug Production Sites and Area Served 8.2.2 Novartis AG Product Introduction, Application and Specification 8.2.3 Novartis AG Pulmonary Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Merck & Co., Inc. 8.3.1 Merck & Co., Inc. Pulmonary Hypertension Drug Production Sites and Area Served 8.3.2 Merck & Co., Inc. Product Introduction, Application and Specification 8.3.3 Merck & Co., Inc. Pulmonary Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Abbott Laboratories 8.4.1 Abbott Laboratories Pulmonary Hypertension Drug Production Sites and Area Served 8.4.2 Abbott Laboratories Product Introduction, Application and Specification 8.4.3 Abbott Laboratories Pulmonary Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Boehringer Ingelheim GmbH 8.5.1 Boehringer Ingelheim GmbH Pulmonary Hypertension Drug Production Sites and Area Served 8.5.2 Boehringer Ingelheim GmbH Product Introduction, Application and Specification 8.5.3 Boehringer Ingelheim GmbH Pulmonary Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 AstraZeneca plc 8.6.1 AstraZeneca plc Pulmonary Hypertension Drug Production Sites and Area Served 8.6.2 AstraZeneca plc Product Introduction, Application and Specification 8.6.3 AstraZeneca plc Pulmonary Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 F. Hoffmann-La Roche AG 8.7.1 F. Hoffmann-La Roche AG Pulmonary Hypertension Drug Production Sites and Area Served 8.7.2 F. Hoffmann-La Roche AG Product Introduction, Application and Specification 8.7.3 F. Hoffmann-La Roche AG Pulmonary Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 Teva Pharmaceutical Industries Ltd. 8.8.1 Teva Pharmaceutical Industries Ltd. Pulmonary Hypertension Drug Production Sites and Area Served 8.8.2 Teva Pharmaceutical Industries Ltd. Product Introduction, Application and Specification 8.8.3 Teva Pharmaceutical Industries Ltd. Pulmonary Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 8.9 Vectura Group plc 8.9.1 Vectura Group plc Pulmonary Hypertension Drug Production Sites and Area Served 8.9.2 Vectura Group plc Product Introduction, Application and Specification 8.9.3 Vectura Group plc Pulmonary Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.9.4 Main Business and Markets Served 8.10 Pfizer Inc. 8.10.1 Pfizer Inc. Pulmonary Hypertension Drug Production Sites and Area Served 8.10.2 Pfizer Inc. Product Introduction, Application and Specification 8.10.3 Pfizer Inc. Pulmonary Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.10.4 Main Business and Markets Served 9 Development Trend of Analysis of Pulmonary Hypertension Drug Market 9.1 Global Pulmonary Hypertension Drug Market Trend Analysis 9.1.1 Global Pulmonary Hypertension Drug Market Size (Volume and Value) Forecast 2019-2025 9.2 Pulmonary Hypertension Drug Regional Market Trend 9.2.1 North America Pulmonary Hypertension Drug Forecast 2019-2025 9.2.2 Europe Pulmonary Hypertension Drug Forecast 2019-2025 9.2.3 China Pulmonary Hypertension Drug Forecast 2019-2025 9.2.4 Japan Pulmonary Hypertension Drug Forecast 2019-2025 9.2.5 Southeast Asia Pulmonary Hypertension Drug Forecast 2019-2025 9.2.6 India Pulmonary Hypertension Drug Forecast 2019-2025 9.3 Pulmonary Hypertension Drug Market Trend (Product Type) 9.4 Pulmonary Hypertension Drug Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Pulmonary Hypertension Drug Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Pulmonary Hypertension Drug Table Global Pulmonary Hypertension Drug Production (MT) Growth Rate Comparison by Types (2014-2025) Figure Global Pulmonary Hypertension Drug Production Market Share by Types in 2018 Figure Prostacyclin and Prostacyclin Analogs Product Picture Figure Endothelin Receptor Antagonists Product Picture Figure Phosphodiesterase-5 Inhibitors Product Picture Figure Soluble Guanylate Cyclase Stimulators Product Picture Table Global Pulmonary Hypertension Drug Consumption (MT) Comparison by Applications (2014-2025) Figure Global Pulmonary Hypertension Drug Consumption Market Share by Applications in 2018 Figure Early-stage Drug Candidates (Phase I & Phase II) Figure Late-stage Drug Candidates (Phase III & Registration Phase) Figure Global Pulmonary Hypertension Drug Revenue (Million USD) (2014-2025) Figure Global Pulmonary Hypertension Drug Production (MT) (2014-2025) Figure North America Pulmonary Hypertension Drug Market Size (Million USD) (2014-2025) Figure Europe Pulmonary Hypertension Drug Market Size (Million USD) (2014-2025) Figure China Pulmonary Hypertension Drug Market Size (Million USD) (2014-2025) Figure Japan Pulmonary Hypertension Drug Market Size (Million USD) (2014-2025) Figure Southeast Asia Pulmonary Hypertension Drug Market Size (Million USD) (2014-2025) Figure India Pulmonary Hypertension Drug Market Size (Million USD) (2014-2025) Table Pulmonary Hypertension Drug Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Pulmonary Hypertension Drug in 2018 Figure Manufacturing Process Analysis of Pulmonary Hypertension Drug Figure Industry Chain Structure of Pulmonary Hypertension Drug Table Capacity and Commercial Production Date of Key Manufacturers Table Global Pulmonary Hypertension Drug Manufacturing Plants Distribution Table Pulmonary Hypertension Drug Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Pulmonary Hypertension Drug Capacity (MT) of Major Manufacturers (2014-2019) Table Pulmonary Hypertension Drug Production (MT) of Major Manufacturers (2014-2019) Table Pulmonary Hypertension Drug Production Market Share of Major Manufacturers (2014-2019) Figure Pulmonary Hypertension Drug Production Share by Manufacturers in 2018 Table Pulmonary Hypertension Drug Revenue (Million US$) of Major Manufacturers (2014-2019) Table Pulmonary Hypertension Drug Revenue Market Share of Major Manufacturers (2014-2019) Figure Pulmonary Hypertension Drug Revenue Share by Manufacturers in 2018 Table Pulmonary Hypertension Drug Average Price (USD/Kg) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Pulmonary Hypertension Drug Production by Regions 2014-2019 (MT) Table Global Pulmonary Hypertension Drug Production Market Share by Regions 2014-2019 Figure Global Pulmonary Hypertension Drug Production Market Share by Regions in 2018 Table Global Pulmonary Hypertension Drug Revenue by Regions 2014-2019 (Million USD) Table Global Pulmonary Hypertension Drug Revenue Market Share by Regions 2014-2019 Figure Global Pulmonary Hypertension Drug Revenue Market Share by Regions in 2018 Table Global Pulmonary Hypertension Drug Consumption by Regions 2014-2019 (MT) Table Global Pulmonary Hypertension Drug Consumption Market Share by Regions 2014-2019 Figure North America Pulmonary Hypertension Drug Production Growth Rate 2014-2019 (MT) Figure North America Pulmonary Hypertension Drug Revenue Growth Rate 2014-2019 (Million USD) Table North America Pulmonary Hypertension Drug Production, Consumption Import and Export (MT) Figure Europe Pulmonary Hypertension Drug Production Growth Rate 2014-2019 (MT) Figure Europe Pulmonary Hypertension Drug Revenue Growth Rate 2014-2019 (Million USD) Table Europe Pulmonary Hypertension Drug Production, Consumption Import and Export (MT) Figure China Pulmonary Hypertension Drug Production Growth Rate 2014-2019 (MT) Figure China Pulmonary Hypertension Drug Revenue Growth Rate 2014-2019 (Million USD) Table China Pulmonary Hypertension Drug Production, Consumption Import and Export (MT) Figure Japan Pulmonary Hypertension Drug Production Growth Rate 2014-2019 (MT) Figure Japan Pulmonary Hypertension Drug Revenue Growth Rate 2014-2019 (Million USD) Table Japan Pulmonary Hypertension Drug Production, Consumption Import and Export (MT) Figure Southeast Asia Pulmonary Hypertension Drug Production Growth Rate 2014-2019 (MT) Figure Southeast Asia Pulmonary Hypertension Drug Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Pulmonary Hypertension Drug Production, Consumption Import and Export (MT) Figure India Pulmonary Hypertension Drug Production Growth Rate 2014-2019 (MT) Figure India Pulmonary Hypertension Drug Revenue Growth Rate 2014-2019 (Million USD) Table India Pulmonary Hypertension Drug Production, Consumption Import and Export (MT) Figure Global Consumption Pulmonary Hypertension Drug Market Share by Application (2014-2019) Figure Global Value (Consumption) Pulmonary Hypertension Drug Market Share by Application (2014-2019) Table GlaxoSmithKline plc Pulmonary Hypertension Drug Production Sites and Area Served Table GlaxoSmithKline plc Pulmonary Hypertension Drug Product Introduction, Application and Specification Table GlaxoSmithKline plc Pulmonary Hypertension Drug Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table GlaxoSmithKline plc Pulmonary Hypertension Drug Production Growth Rate (2014-2019) Table GlaxoSmithKline plc Pulmonary Hypertension Drug Production Market Share (2014-2019) Figure GlaxoSmithKline plc Pulmonary Hypertension Drug Revenue Market Share (2014-2019) Table GlaxoSmithKline plc Pulmonary Hypertension Drug Main Business and Markets Served Table Novartis AG Pulmonary Hypertension Drug Production Sites and Area Served Table Novartis AG Pulmonary Hypertension Drug Product Introduction, Application and Specification Table Novartis AG Pulmonary Hypertension Drug Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Novartis AG Pulmonary Hypertension Drug Production Growth Rate (2014-2019) Table Novartis AG Pulmonary Hypertension Drug Production Market Share (2014-2019) Figure Novartis AG Pulmonary Hypertension Drug Revenue Market Share (2014-2019) Table Novartis AG Pulmonary Hypertension Drug Main Business and Markets Served Table Merck & Co., Inc. Pulmonary Hypertension Drug Production Sites and Area Served Table Merck & Co., Inc. Pulmonary Hypertension Drug Product Introduction, Application and Specification Table Merck & Co., Inc. Pulmonary Hypertension Drug Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Merck & Co., Inc. Pulmonary Hypertension Drug Production Growth Rate (2014-2019) Table Merck & Co., Inc. Pulmonary Hypertension Drug Production Market Share (2014-2019) Figure Merck & Co., Inc. Pulmonary Hypertension Drug Revenue Market Share (2014-2019) Table Merck & Co., Inc. Pulmonary Hypertension Drug Main Business and Markets Served Table Abbott Laboratories Pulmonary Hypertension Drug Production Sites and Area Served Table Abbott Laboratories Pulmonary Hypertension Drug Product Introduction, Application and Specification Table Abbott Laboratories Pulmonary Hypertension Drug Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Abbott Laboratories Pulmonary Hypertension Drug Production Growth Rate (2014-2019) Table Abbott Laboratories Pulmonary Hypertension Drug Production Market Share (2014-2019) Figure Abbott Laboratories Pulmonary Hypertension Drug Revenue Market Share (2014-2019) Table Abbott Laboratories Pulmonary Hypertension Drug Main Business and Markets Served Table Boehringer Ingelheim GmbH Pulmonary Hypertension Drug Production Sites and Area Served Table Boehringer Ingelheim GmbH Pulmonary Hypertension Drug Product Introduction, Application and Specification Table Boehringer Ingelheim GmbH Pulmonary Hypertension Drug Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Boehringer Ingelheim GmbH Pulmonary Hypertension Drug Production Growth Rate (2014-2019) Table Boehringer Ingelheim GmbH Pulmonary Hypertension Drug Production Market Share (2014-2019) Figure Boehringer Ingelheim GmbH Pulmonary Hypertension Drug Revenue Market Share (2014-2019) Table Boehringer Ingelheim GmbH Pulmonary Hypertension Drug Main Business and Markets Served Table AstraZeneca plc Pulmonary Hypertension Drug Production Sites and Area Served Table AstraZeneca plc Pulmonary Hypertension Drug Product Introduction, Application and Specification Table AstraZeneca plc Pulmonary Hypertension Drug Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table AstraZeneca plc Pulmonary Hypertension Drug Production Growth Rate (2014-2019) Table AstraZeneca plc Pulmonary Hypertension Drug Production Market Share (2014-2019) Figure AstraZeneca plc Pulmonary Hypertension Drug Revenue Market Share (2014-2019) Table AstraZeneca plc Pulmonary Hypertension Drug Main Business and Markets Served Table F. Hoffmann-La Roche AG Pulmonary Hypertension Drug Production Sites and Area Served Table F. Hoffmann-La Roche AG Pulmonary Hypertension Drug Product Introduction, Application and Specification Table F. Hoffmann-La Roche AG Pulmonary Hypertension Drug Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table F. Hoffmann-La Roche AG Pulmonary Hypertension Drug Production Growth Rate (2014-2019) Table F. Hoffmann-La Roche AG Pulmonary Hypertension Drug Production Market Share (2014-2019) Figure F. Hoffmann-La Roche AG Pulmonary Hypertension Drug Revenue Market Share (2014-2019) Table F. Hoffmann-La Roche AG Pulmonary Hypertension Drug Main Business and Markets Served Table Teva Pharmaceutical Industries Ltd. Pulmonary Hypertension Drug Production Sites and Area Served Table Teva Pharmaceutical Industries Ltd. Pulmonary Hypertension Drug Product Introduction, Application and Specification Table Teva Pharmaceutical Industries Ltd. Pulmonary Hypertension Drug Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Teva Pharmaceutical Industries Ltd. Pulmonary Hypertension Drug Production Growth Rate (2014-2019) Table Teva Pharmaceutical Industries Ltd. Pulmonary Hypertension Drug Production Market Share (2014-2019) Figure Teva Pharmaceutical Industries Ltd. Pulmonary Hypertension Drug Revenue Market Share (2014-2019) Table Teva Pharmaceutical Industries Ltd. Pulmonary Hypertension Drug Main Business and Markets Served Table Vectura Group plc Pulmonary Hypertension Drug Production Sites and Area Served Table Vectura Group plc Pulmonary Hypertension Drug Product Introduction, Application and Specification Table Vectura Group plc Pulmonary Hypertension Drug Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Vectura Group plc Pulmonary Hypertension Drug Production Growth Rate (2014-2019) Table Vectura Group plc Pulmonary Hypertension Drug Production Market Share (2014-2019) Figure Vectura Group plc Pulmonary Hypertension Drug Revenue Market Share (2014-2019) Table Vectura Group plc Pulmonary Hypertension Drug Main Business and Markets Served Table Pfizer Inc. Pulmonary Hypertension Drug Production Sites and Area Served Table Pfizer Inc. Pulmonary Hypertension Drug Product Introduction, Application and Specification Table Pfizer Inc. Pulmonary Hypertension Drug Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Pfizer Inc. Pulmonary Hypertension Drug Production Growth Rate (2014-2019) Table Pfizer Inc. Pulmonary Hypertension Drug Production Market Share (2014-2019) Figure Pfizer Inc. Pulmonary Hypertension Drug Revenue Market Share (2014-2019) Table Pfizer Inc. Pulmonary Hypertension Drug Main Business and Markets Served Figure Global Pulmonary Hypertension Drug Production (MT) Growth Rate Forecast 2019-2025 Figure Global Pulmonary Hypertension Drug Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Pulmonary Hypertension Drug Sales Price (USD/Kg) Forecast 2019-2025 Figure North America Pulmonary Hypertension Drug Production Growth Rate Forecast 2019-2025 (MT) Figure North America Pulmonary Hypertension Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Pulmonary Hypertension Drug Production Growth Rate Forecast 2019-2025 (MT) Figure Europe Pulmonary Hypertension Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Pulmonary Hypertension Drug Production Growth Rate Forecast 2019-2025 (MT) Figure China Pulmonary Hypertension Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Pulmonary Hypertension Drug Production Growth Rate Forecast 2019-2025 (MT) Figure Japan Pulmonary Hypertension Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Pulmonary Hypertension Drug Production Growth Rate Forecast 2019-2025 (MT) Figure Southeast Asia Pulmonary Hypertension Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Pulmonary Hypertension Drug Production Growth Rate Forecast 2019-2025 (MT) Figure India Pulmonary Hypertension Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (MT) of Pulmonary Hypertension Drug by Type (2019-2025) Table Global Consumption (MT) of Pulmonary Hypertension Drug by Application (2019-2025) Table Pulmonary Hypertension Drug Distributors List Table Pulmonary Hypertension Drug Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

GlaxoSmithKline plc Novartis AG Merck & Co., Inc. Abbott Laboratories Boehringer Ingelheim GmbH AstraZeneca plc F. Hoffmann-La Roche AG Teva Pharmaceutical Industries Ltd. Vectura Group plc Pfizer Inc.